|
1
|
Yan YB: Creatine kinase in cell cycle
regulation and cancer. Amino Acids. 48:1775–1784. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kazak L and Cohen P: Creatine metabolism:
Energy homeostasis, immunity and cancer biology. Nat Rev
Endocrinol. 16:421–436. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Murayama K, Suzuki T, Yajima S, Oshima Y,
Nanami T, Shiratori F and Shimada H: Preoperative low serum
creatine kinase is associated with poor overall survival in the
male patients with esophageal squamous cell carcinoma. Esophagus.
12:105–112. 2022. View Article : Google Scholar
|
|
4
|
Yamazaki N, Oshima Y, Shiratori F, Nanami
T, Suzuki T, Yajima S, Funahashi K and Shimada H: Prognostic
significance of preoperative low serum creatine kinase levels in
gastric cancer. Surg Today. 52:1551–1559. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pan H, Xia K, Zhou W, Xue J, Liang X, Chen
L, Wu N, Liang M, Wu D, Ling L, et al: Low serum creatine kinase
levels in breast cancer patients: A case-control study. PLoS One.
8:e621122013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu L, He Y, Ge G, Li L, Zhou P, Zhu Y,
Tang H, Huang Y, Li W and Zhang: Lactate dehydrogenase and creatine
kinase as poor prognostic factors in lung cancer: A retrospective
observational study. PLoS One. 12:e01821682017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Takamori S, Toyokawa G, Shimokawa M,
Kinoshita F, Kazuma Y, Matsubara T, Haratake N, Akamine T, Hirai F,
Tagawa T, et al: A novel prognostic marker in patients with
non-small cell lung cancer: Musculo- immuno-nutritional score
calculated by controlling nutritional status and creatine kinase. J
Thorac Dis. 11:927–935. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Forner A, Reig M and Bruix J:
Hepatocellular carcinoma. Lancet. 391:1301–1314. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Qin LX and Tang ZY: The prognostic
significance of clinical and pathological features in
hepatocellular carcinoma. World J Gastroenterol. 8:193–199. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Befeler AS and Di Bisceglie AM:
Hepatocellular carcinoma: Diagnosis and treatment.
Gastroenterology. 122:1609–1610. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ho EY, Cozen ML, Shen H, Lerrigo R,
Trimble E, Ryan JC, Covera CU and Monto A; HOVAS Group
(Hepatocellular Carcinoma Treatment Outcome at VA San Francisco), :
Expanded use of aggressive therapies improves survival in early and
intermediate hepatocellular carcinoma. HPB (Oxford). 16:758–767.
2015. View Article : Google Scholar
|
|
12
|
Liu Y, Shi M, Chen S, Wan W, Shen L, Shen
B, Qui H, Cao F, Wu Y, Huang T, et al: Intermediate stage
hepatocellular carcinoma: Comparison of the value of
inflammation-based scores in predicting progression-free survival
of patients receiving transarterial chemoembolization. J Cancer Res
Ther. 17:740–748. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yanagaki M, Haruki K, Taniai T, Igarashi
Y, Yasuda J, Furukawa K, Onda S, Shirai Y and Tsunematsu M: The
significance of osteosarcopenia as a predictor of the long-term
outcomes in hepatocellular carcinoma after hepatic resection. J
Hepatobiliary Pancreat Sci. 30:453–461. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kanemitsu F, Kawanishi I, Mizushima J and
Okigaki T: Mitochondrial creatine kinase as a tumor-associated
marker. Clin Chim Acta. 138:175–183. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kanda Y: Investigation of the freely
available easy-to-use software ‘EZR’ for medical statistics. Bone
Marrow Transplant. 48:452–458. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Neal RC, Ferdinand KC, Ycas J and Miller
E: Relationship of ethnic origin, gender, and age to blood creatine
kinase levels. Am J Med. 122:73–78. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hackney AC, Kallman AL and Ağgön E: Female
sex hormones and the recovery from: Menstrual cycle phase affects
responses. Biomed Hum Kinet. 11:87–89. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen C, Lin X, Lin R, Huang H and Lu F: A
high serum creatine kinase (CK)-MB-to-total-CK ratio in patients
with pancreatic cancer: A novel application of a traditional marker
in predicting malignancy of pancreatic masses? World J Surg Oncol.
21:132023. View Article : Google Scholar : PubMed/NCBI
|
